Johnson & Johnson MedTech has received U.S. $0.5 million regulatory clearance for MONARCH QUEST, the latest advancement in its MONARCH navigation technology. This new system features AI-powered algorithms and a verified interface with the GE HealthCare OEC 3D mobile CBCT Imaging System. The MONARCH Platform, the first robotically assisted bronchoscopy system on the market, allows minimally invasive access to lung airways for diagnosing suspicious lung nodules. With nearly half of early-stage lung lesions located in hard-to-reach areas, MONARCH QUEST aims to improve the accuracy of biopsies and speed up the diagnosis process, helping patients begin treatment up to three weeks earlier.
MONARCH QUEST enhances the system’s precision through its scope-in-sheath design, continuous vision capabilities, and integration with real-time 3D imaging data. The system now uses the NVIDIA accelerated computing platform, increasing computational power by 260 percent to improve navigation accuracy. The platform also supports future AI-driven software advancements as the demand for robotically assisted bronchoscopy grows. Extending beyond the procedure, the MONARCH Platform offers digital capabilities from preoperative planning through post-operative data analysis. This technology is part of Johnson & Johnson’s Polyphonic digital ecosystem, which connects data across surgical technologies and robotics to improve patient care and support medical professionals in delivering more accurate diagnoses.
